GENOVA, Inc. (TYO:9341)
Japan
· Delayed Price · Currency is JPY | Market Cap | 9.60B |
| Revenue (ttm) | 10.32B |
| Net Income (ttm) | 377.71M |
| Shares Out | 17.33M |
| EPS (ttm) | 21.53 |
| PE Ratio | 25.73 |
| Forward PE | n/a |
| Dividend | 30.00 (5.42%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 30,700 |
| Average Volume | 45,470 |
| Open | 548.00 |
| Previous Close | 549.00 |
| Day's Range | 546.00 - 554.00 |
| 52-Week Range | 541.00 - 1,037.00 |
| Beta | -0.18 |
| RSI | 38.91 |
| Earnings Date | May 12, 2026 |
About GENOVA
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. In addition, the company offers NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay mac... [Read more]
Financial Performance
In fiscal year 2025, GENOVA's revenue was 10.01 billion, an increase of 15.24% compared to the previous year's 8.68 billion. Earnings were 1.41 billion, a decrease of -18.13%.
Financial StatementsNews
Check Your Pantry ASAP for This Recalled Canned Tuna Brand
Tri-Union Seafoods announced a recall of canned tuna sold under the Trader Joe's, Genova, Van Camp's and H-E-B brand names due to quality and safety concerns.